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Abstract
Background: The membrane-associated and membrane-spanning constituents of the Schistosoma mansoni tegument
surface, the parasite’s principal interface with the host bloodstream, have recently been characterized using proteomic
techniques. Biotinylation of live worms using membrane-impermeant probes revealed that only a small subset of the
proteins was accessible to the reagents. Their position within the multilayered architecture of the surface has not been
ascertained.
Methodology/Principal Findings: An enzymatic shaving approach on live worms has now been used to release the most
accessible components, for analysis by MS/MS. Treatment with trypsin, or phosphatidylinositol-specific phospholipase C
(PiPLC), only minimally impaired membrane integrity. PiPLC-enriched proteins were distinguished from those released in
parasite vomitus or by handling damage, using isobaric tagging. Trypsin released five membrane proteins, Sm200, Sm25
and three annexins, plus host CD44 and the complement factors C3 and C4. Nutrient transporters and ion channels were
absent from the trypsin fraction, suggesting a deeper location in the surface complex; surprisingly, two BAR-domain
containing proteins were released. Seven parasite and two host proteins were enriched by PiPLC treatment, the vaccine
candidate Sm29 being the most prominent along with two orthologues of human CD59, potentially inhibitors of
complement fixation. The enzymes carbonic anhydrase and APD-ribosyl cyclase were also enriched, plus Sm200 and alkaline
phosphatase. Host GPI-anchored proteins CD48 and CD90, suggest ‘surface painting’ during worm peregrination in the
portal system.
Conclusions/Significance: Our findings suggest that the membranocalyx secreted over the tegument surface is not the
inert barrier previously proposed, some tegument proteins being externally accessible to enzymes and thus potentially
located within it. Furthermore, the detection of C3 and C4 indicates that the complement cascade is initiated, while two
CD59 orthologues suggest a potential mechanism for its inhibition. The detection of several host proteins is a testimonial to
the acquisitive properties of the tegument surface. The exposed parasite proteins could represent novel vaccine candidates
for combating this neglected disease.
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Introduction
The persistence of adult schistosomes in the bloodstream for
decades means they must deploy unique and effective immune
evasion strategies at their interface with the host. The 1 cm-long
worms are covered by a naked syncytial layer of cytoplasm, the
tegument, connected by cytoplasmic tubules to underlying cell
bodies that contain the machinery for protein synthesis, packaging
and export. The tegument surface has a multilaminate appear-
ance, interpreted as a plasma membrane overlain by a lamellate
secretion, the membranocalyx [1]. This complex molecular
architecture is maintained by export of the contents of multi-
laminate vesicles, which originate in the cell bodies of the
syncytium. There is experimental evidence for slow turnover of
the membranocalyx to the external environment [2] whilst
recycling of the plasma membrane by internalisation has been
anticipated but not conclusively demonstrated [3]. Initial obser-
vations suggested the membranocalyx was an amphipathic bilayer,
probably composed of phospholipids, which served as a physical
barrier to prevent antibody binding or host leukocyte attachment
to the underlying plasma membrane. In addition, its supposed
hydrophobic properties coincided with a demonstrable ability of
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erythrocyte glycolipids (the so-called host antigens) [4]. Whether
this acquisition is a deliberate process that benefits the parasite or
an accidental consequence of the membranocalyx properties, and
any relevance it has to immune evasion, remain unclear.
Building on techniques developed in 1980s to detach the
tegument by freeze-thaw and enrich the surface membrane
complex by differential centrifugation [5], we have characterized
its composition using proteomic techniques [6,7]. We developed a
differential extraction scheme for the membrane preparation, with
chaotropic agents of increasing strength, which enabled us to
identify both membrane-associated and membrane-spanning
constituents. These compositional findings demonstrated the
importance of the tegument for nutrient uptake and maintenance
of solute balance, as well as the presence of several hydrolases in
the surface layers [6]. In a second study we incubated live worms
with membrane-impermeant probes to biotinylate the most
externally-accessible proteins and then recovered the tagged
molecules by affinity chromatography for MS/MS identification
[7]. This approach revealed that only a small subset of
transporters, membrane structural proteins, enzymes, and schis-
tosome-unique proteins were labelled, together with host immu-
noglobulins and complement C3. We concluded that these
represented the most ‘‘exposed’’ surface constituents but we could
not place them within the multilayered architecture of the surface
with any certainty.
To add another dimension to our understanding of tegument
surface organization we have now used an enzymatic shaving
approach on live worms to release the components most accessible
to the selected enzymes, for MS/MS analysis. By analogy with
techniques for stripping adherent cells from culture flasks, we used
trypsin to cleave exposed protein loops or domains without
impairing membrane integrity. We also incubated worms with
phosphatidylinositol-specific phospholipase C (PiPLC) to release
any externally accessible GPI-anchored proteins. As a control for
proteins released by the vomiting of gut contents during the
incubation period, or damage due to handling, we compared
protein release +/2 PiPLC, using the iTRAQ technique. Finally
we used a phospholipase A2 (PLA2) preparation purified from
snake venom to erode the lipid bilayer complex to determine if
proteins could be selectively detached. We report that both trypsin
and PiPLC removed a small subset of proteins whilst inflicting
minimal damage on the worms whereas PLA2 was more
destructive. We show that the iTRAQ technique identified both
parasite and host proteins enriched by PiPLC treatment whereas
trypsin released a different subset, with only Sm200 common to
both. The proteins we have identified in the adult are also present
as transcripts in the lung schistosomulum. We suggest that
collectively they may be candidates for a schistosome vaccine,
especially if responses can be targeted to the lungs to interfere with
intravascular migration of incoming larvae.
Methods
Ethics statement
The procedures involving animals were carried out in
accordance with the UK Animals (Scientific Procedures) Act
1986, and authorised on personal and project licences issued by
the UK Home Office. The study protocol was approved by the
Biology Department Ethical Review Committee at the University
of York.
Parasite maintenance and worm recovery
A Puerto Rican isolate of S. mansoni was maintained using albino
Biomphalaria glabrata snails and NMRI strain mice as laboratory
hosts. All animal experiments were approved by the Ethical
Review Process Committee of the Department of Biology,
University of York. Adult parasites were obtained by portal
perfusion of mice seven weeks after exposure to 200 cercariae,
using RPMI1640 medium (minus phenol red) buffered with
10 mM HEPES (both from Invitrogen, Paisley, UK). Parasites
were extensively washed in the same medium and tissue debris and
any damaged individuals removed under a dissecting microscope.
No attempt was made to separate males from females.
Trypsin treatment of live parasites and recovery of
peptides
Approximately 800 freshly perfused parasites from 20 mice were
used in each of four replicate experiments with trypsin as the
shaving enzyme. They were incubated in a 30 mL Corning flask
(Corning, NY, USA) containing 5 mL of buffered RPMI, with
trypsin MS (Promega, Southampton, UK) added at 10 mg/mL, for
30 min at room temperature (RT). The supernatant was
recovered, transferred to a 15 mL Falcon tube and centrifuged
at 5006g for 30 min to remove any insoluble material such as the
haematin particles in gut vomitus. Streptomycin and penicillin
were then added to a final concentration of 100 mg/mL to prevent
microbial growth and tryptic digestion was continued overnight at
37uC, after which peptides were reduced and alkylated. Reduction
was performed in the presence of 20 mM DTT for 30 min at
65uC in a water bath and, after cooling, alkylation was performed
in the presence of 80 mM iodoacetamide for 1 h at RT in the
dark. Trifluoroacetic acid (TFA) was then added to a final
concentration of 0.1% before recovery of peptides by passage
through a solid phase Strata C18-E extraction cartridge (55 mm,
Phenomenex, Macclesfield, UK), followed by several column
washes in 0.1% TFA and final elution in 750 mL of 50%
acetonitrile/0.1% TFA. The eluted fraction was concentrated
under vacuum to dryness and peptides resuspended in 20 mL 0.1%
TFA.
LC-MS/MS
A3mL aliquot of the tryptic peptide preparation was injected
onto a reversed-phase PS-DVB monolith column (200 mm
i.d.65 cm, LC Packings, Amsterdam, Netherlands). Peptides were
separated using a two-step linear gradient of 2–31.4% (v/v)
Author Summary
Adult schistosome parasites can reside in the host
bloodstream for decades surrounded by components of
the immune system. It was originally proposed that their
survival depended on the secretion of an inert bilayer, the
membranocalyx, to protect the underlying plasma mem-
brane from attack. We have investigated whether any
proteins were exposed on the surface of live worms using
incubation with selected hydrolases, in combination with
mass spectrometry to identify released proteins. We show
that a small number of parasite proteins are accessible to
the enzymes and so could represent constituents of the
membranocalyx. We also identified several proteins
acquired by the parasite on contact with host cells. In
addition, components of the cytolytic complement path-
way were detected, but these appeared not to harm the
worm, indicating that some of its own surface proteins
could inhibit the lytic pathway. We suggest that,
collectively, the ‘superficial’ parasite proteins may provide
good candidates for a schistosome vaccine.
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followed by 31.4–51% (v/v) in the same solvent over 5 min, at a
flow rate of 3 mL/min; UV absorbance at 214 nm was monitored.
Fractions were collected onto a MALDI target plate using a
Probot (Dionex, Bannockburn, USA) with simultaneous addition
of matrix solution (6 mg/mL a-cyano-4-hydroxycinamic acid
(CHCA, Sigma, Poole, UK) in 60% (v/v) acetonitrile).
Positive-ion MALDI mass spectra (MS) were obtained using a
4700 Proteomics Analyzer with TOF-TOF Optics (Applied
Biosystems, Framingham, USA) in reflector mode, over the m/z
range 800–4000 and monoisotopic masses obtained from
centroids of raw, unsmoothed data. The precursor mass window
was set to a relative resolution of 50, and the metastable supp-
ressor was enabled. The default calibration was used for MS/MS
spectra, which were baseline-subtracted (peak width 50) and
smoothed (Savitsky-Golay with three points across a peak and
polynomial order 4); peak detection used a minimum S/N of 5,
local noise window of 50 m/z, and minimum peak width of 2.9
bins. The twenty strongest peaks from each fraction, having a
signal to noise (S/N) greater than 50 and a fraction-to-fraction
precursor exclusion of 60.2 Da, were selected for CID-MS/MS
analysis. Singly-charged peptides were fragmented with Source 1
collision energy of 1 keV, and air as the collision gas. Peak lists
from the MS/MS data, containing all m/z values from m/z 20 to
the precursor m/z - 60, with a minimum S/N of 10, were
provided by TS2 software (version 1.0.0, Matrix Science Ltd.,
London, UK). Each list, corresponding to one MALDI plate, was
then submitted to a local copy of the Mascot program (version
2.1, Matrix Science) and searched against the SmGenesPlusESTs
(260448 sequences; 71029272 residues), an in-house database
derived from the publically available data in http://www.genedb.
org/genedb/smansoni/), and the NCBInr Mus musculus database
(139457 sequences) for host proteins. Search parameters specified
only tryptic cleavages and allowed for up to one missed site, the
variable carbamidomethylation of cysteines, and oxidation of
methionines; precursor and product ion mass error tolerance was
set to 60.3 Da. A decoy database, generated by Mascot, was
used with the significance threshold for protein identification set
to achieve a false positive rate of 1 to 2% and peptide threshold
set to ‘least identity’. A protein was considered positively
identified if the ion score for a particular peptide had an expect
value less than 0.05.
Phosphatidylinositol-phospholipase C (PiPLC) treatment
of live parasites
GPI-anchored proteins were recovered from live worms by in
vitro incubation with PiPLC as the shaving enzyme, the experiment
being performed twice to provide biological replicates. Down-
stream analysis required the worms from 40 mice, which were
perfused and treated in two separate batches to minimise the time
ex vivo; supernatants were then combined. Each batch was
incubated at 37uC for 1 h in the presence of PiPLC (from Bacillus
cereus, Sigma) at 1.25 Units/mL, with conditions as for trypsin. The
supernatant was removed and concentrated at 4uC using a
5000 Da cut-off centrifugation device (Vivaspin 6, West Sussex,
UK). The control for secretion, vomitus production and parasite
damage due to handling comprised an identical experiment, minus
PiPLC. This also served as a ‘background’ control for the other
enzyme treatments. For one experiment, PiPLC-released proteins
were obtained using PiPLC from a different source (from Bacillus
thuringiensis, Europa Bioproducts, Wicken, Cambridigeshire, UK)
employing the same conditions as above. On that occasion the
GPI-released fraction was used for a 2-DE separation.
Fractionation of the PiPLC-released material
The composition of released material was evaluated by 1-DE
using a pre-cast NUPAGE 4–12% Bis-Tris gel (Invitrogen) after a
45 min run at 200 V. The gel was then fixed in 40% methanol,
10% acetic acid for 30 min, stained with SYPRO Ruby
(Invitrogen) for 2 h in the dark and imaged using a Molecular
Imager FX (Bio-Rad, Bath, UK). Protein content in each lane of
the gel was then estimated by densitometric analysis using
Quantity One software (Bio-Rad). Fifty mg of the PiPLC-treated
sample was also evaluated by mini 2-DE essentially as previously
described [8,9]. After electrophoresis the gel was first stained with
SYPRO Ruby, imaged as above, and restained with Bio-Safe
Coomassie (BioRad); all visible spots were selected for ‘‘in gel’’
digestion [8]. An aliquot of 1–2 mL of the digestion supernatant
containing the peptides was spotted on a MALDI plate and dried
before the addition of 0.6 mL of a saturated solution of CHCA
matrix (in 50% acetonitrile/0.1% TFA). Peptide fragmentation
data from each gel spot was processed by GPS Explorer Software
(Applied Biosystems) underpinned by Mascot (settings as above), to
provide a putative identity for the protein.
iTRAQ labelling of peptides
The relative composition of PiPLC-treated and control samples
was characterized using isobaric tagging (the iTRAQ labelling
technique) following the protocol provided by the manufacturer
(Applied Biosystems). Prior to labelling, two aliquots of treated and
control samples containing 10 mg protein were taken to provide
technical replicates. Briefly, 10 mg of both control and PiPLC-
treatedsampleswere individually denatured,reduced,andalkylated
with reagents supplied in the iTRAQ kit. Peptides were generated
by trypsin digestion using a 1:20 enzyme/protein ratio, at 37uC for
24 h, and labelled with iTRAQ reagents at lysine, terminal amine
groups and partially at tyrosine residues. Test samples were labelled
with tags 116 or 117 and control samples with tags 114 or 115,
respectively. A peptide mixture was made by combining the four
tagged samples and cleaned up using a strong cation-exchange
cartridge to remove the detergents and excess iTRAQ reagents.
Thepeptideswerethen affinity-purifiedina StrataC18-E cartridge,
eluted as for tryptic peptides, dried using a vacuum concentrator
and resuspended in 10–20 mL of 0.1% TFA. LC-MS/MS was
performed as described above. Protein identification and peptide
quantification was achieved by submitting the TS2-generated MS/
MS raw data files to Mascot, searching against SmGenesPlusESTs
and NCBInr databases. Search parameters were tryptic peptides,
with0–1 missed cleavage; fixed modifications, b-methylthiolation of
cysteines, iTRAQ tagging of lysines and N-terminal amine groups;
variable modifications were oxidation of methionines and iTRAQ
tagging of tyrosines. Precursor and product ion mass error tolerance
was set to 60.3 Da.
The 114-tagged sample (C1) was taken as the reference for
calculating ratios. The Mascot software displays the median
normalised geometric mean ratios and a factor from which the
geometric standard deviation can be derived. Automatic outlier
removal was performed by the Mascot software. A protein was
considered enriched if the mean T1/C1 and/or T2/C1 ratios
minus the 95% confidence limit exceeded the corresponding C2/
C1 ratio plus its 95% confidence limit. For single peptide
identifications, a protein was considered enriched if it appeared
in both biological replicate experiments, and had a mean treated/
control ratio .2.
Phospholipase A2 (PLA2) treatment of live parasites
The final approach for recovery of parasite surface molecules
using enzymatic shaving, involved the treatment of live parasites
Enzymatic Shaving of Schistosome Surface Proteins
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durissus terrificus (deposited under accession number P24027 at
NCBInr) was kindly provided by Prof. Andreimar Soares (Faculty
of Pharmaceutical Sciences, University of Sao Paulo, Brazil).
During the shaving experiment, approximately 800 freshly
perfused parasites were incubated in a 30 mL Corning flask,
containing 6 mL of buffered RPMI1640, with PLA2 added at
16 mg/mL for 1 h, at RT. Another batch of parasites was used in a
control and parallel experiment in which no enzyme was added to
the culture medium. The supernatants from control and treated
samples were concentrated using a Vivaspin 6 filtration device
(5000 Da cut off) at 5006g,a t4 uC until the volume reached
500 mL. The samples were then transferred to 1.5 ml eppendorf
tubes and centrifuged at 25,0006g for 20 min. After this step a
membranous pellet, recovered from PLA2-treated parasites only,
was extracted in 50 mL of 0.5% Triton-X100, yielding approxi-
mately 20 mg of protein. Reduction, alkylation, trypsin digestion
and peptide clean-up were performed as described for the iTRAQ
protocol (omitting the labelling steps). LC-MS/MS of the peptide
mixture was performed essentially as described above.
Immunocytochemical localization of host membrane
proteins by confocal microscopy
Host plasma membrane proteins on the surface of adult
parasites were investigated either on live worms, perfused from
mice using RPMI medium, or by preparing OTC-embedded
cryostat sections. Both were incubated with primary antibodies at
1:100 dilution in PBS for parasite sections and in RPMI for live
worms, containing 5% normal goat serum, for 1 h at RT.
Monoclonal antibodies used were rat anti-mouse CD44 (558739),
rat anti-mouse CD90 (Thy-1; 553016) and hamster anti-mouse
CD48 (553682), all from BD Biosciences Pharmingen, New Jersey,
USA. Labelling was detected by the use of goat anti-rat IgG
conjugated to Alexa fluor 488 at 1:500 dilution for 30 min in the
same buffer, or goat anti-hamster IgG conjugated to Alexa fluor
568 under the same conditions.
Transcript searching
A searchable database was created in 2005, comprising all S.
mansoni transcripts then available from dbEST (http://www.ncbi.
nlm.nih.gov/), the Sao Paulo Schistosoma mansoni EST genome
project (http://bioinfo.iq.usp.br/schisto/), and the Wellcome Trust
Sanger Institute ftp site (ftp://ftp.sanger.ac.uk/pub/pathogens/
Schistosoma/mansoni/ESTs). All proteins of interest identified by
the enzymatic shaving approach were searched against the com-
piled EST data to determine the number of transcripts detected in
adults and lung stage schistosomula; this provided a very
approximate guide to the relative levels of expression in the two
life cycle stages.
Results
Enzymatic shaving using MS grade trypsin
Freshly perfused live parasites were subjected to trypsin
digestion under controlled conditions, in order to release from
the surface membrane complex of the tegument any proteins, or
segments thereof, accessible to the enzyme. The vast majority of
worms retained a normal appearance and activity over the 30 min
incubation. The culture supernatant was recovered and released
proteins/peptides allowed to digest further overnight. Tryptic
peptides were then reduced and alkylated before their recovery
and separation using reversed-phase chromatography (Figure S1A)
for subsequent mass-spectrometric identification. The identities
obtained by Mascot searching of the MS/MS data were then
categorized according to their molecular function and, by
inference, their potential cellular origin (Table 1).
The host complement proteins C3 and C4 and the leukocyte
surface marker CD44 were released in two or more of the four
replicate experiments. Host haemoglobin alpha and beta chains
were also identified in one experiment, presumably an indication
that regurgitation from the worm gut was occurring. A number of
proteins, known to be associated with the tegument surface, were
also released by the treatment. They included three phospholipid-
binding annexins and the membrane protease calpain. Of the
annexins, Smp_077720 was found in all four experiments and the
others on two and one occasions, respectively; calpain was
detected in only one experiment. The schistosome-unique proteins
of unknown function, Sm200 and Sm25, were found on three and
four occasions, respectively. The final membrane protein, not
previously associated with the tegument, shows homology with cell
surface proteoglycans. A pair of BAR-domain-containing endo-
philins was also released by the treatment in all four experiments
while the putative potassium-channel inhibitor, SmKK7, was
found on one occasion.
Although worm incubations were short-term, two known gut-
derived proteases, asparaginyl endopeptidase and cathepsin B1
were detected. In addition, a total of 12 proteins with unknown
function and localization were found (Tables S1 and S2), some
containing domains, e.g. Ig-like and EGF-like, which may indicate
a surface position. In spite of strenuous efforts to maintain worm
viability, the trypsin treatment affected the integrity of the surface
membranes to some extent, as evidenced by the appearance of
seven cytoskeletal and 17 cytosolic proteins in the medium (Tables
S1 and S2). Among the former, actin, fimbrin and severin have
been proposed as constituents of the tegumental spines that reside
immediately beneath the surface membrane complex. The more
numerous cytosolic proteins, comprising glycolytic enzymes,
chaperones, and antioxidants indicate the leakage of internal
components in at least some of the parasites. Known tegumental
surface transporters, ion channels, and enzymes (other than
calpain) were conspicuous by their absence in the trypsin
preparation.
Enzymatic shaving using PiPLC
The purpose of treatment with PiPLC was to release GPI-
anchored proteins accessible to the externally applied enzyme in
live worms; incubation with the enzyme for 1 h appeared to have
no morphologically obvious deleterious effect. A 1-DE gel
separation of material released by treated and control worms
revealed a complex pattern of protein bands with Mr ranging from
10 to .250 kDa (Figure 1A). The two preparations displayed a
strong similarity, with only three bands (arrowed) visibly enriched
by the PiPLC treatment versus the control; two were of high
molecular mass (approx. 200 kDa) while the other was located at
the bottom of the gel (approx. 12 kDa). The PiPLC treatment
released sufficient protein to permit a mini 2-DE separation
(Figure 1B) for subsequent MS/MS analysis of gel spots. The
analysis revealed the presence of proteins known to be GPI-
anchored, such as ‘Surface protein’ (Sm200) and alkaline phosph-
atase. Protein orthologues of CD59 and carbonic anhydrase IV
were novel features of this 2D map. The absence of gut proteases
Sm31 and Sm32 was notable. The identities of other spots
revealed the presence of cytosolic and cytoskeletal contaminants,
including thioredoxin, fatty acid binding protein (Sm14), Sm22.6,
enolase and triose phosphate isomerase (Table S3). The remaining
spots on the SYPRO-stained gel (Figure 1B) were not detected by
Coomassie staining so no identification could be assigned using
single spot tryptic digestion.
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1 h incubation irrespective of whether PiPLC was present or not,
we used the iTRAQ technique to determine the degree of
enrichment due solely to the enzymatic shaving. Within an
individual labelling protocol, splitting both the control and
treatment samples provided technical replicates. After LC
separation of the tagged peptide mixture (Figure S1B), fragmen-
tation spectra of the most abundant peptides were generated, each
containing signature peaks for the four reporter tags (Figure 2 and
Figure S2). In most instances the fragmentation spectra yielded
four peaks of approximately equal area (Figure 2A). The 115/114
(C2/C1) ratios approximated to unity, indicating approximately
equal protein contributions of the two control samples to the
iTRAQ mixture. However, the majority of 116/114 (T1/C1) and
117/114 (T2/C1) ratios were almost invariably less than one,
sometimes significantly so (Figure 2A and Figure S2). We have no
reason to believe that the control and treatment incubations
differed except in the addition of enzyme, and so we must attribute
the ratios of less than unity to a dilution effect on the background
proteins in the treated samples. This dilution resulted from the
addition of PiPLC plus the extra proteins released from the surface
by its action. In a minority of fragmentation spectra the four peaks
representing the reporter tags were not of approximately uniform
area (Figure 2B and Figure S2). The reporter ion peaks from the
treated samples were from 2 to 10 fold greater intensity indicating
enrichment of the parent peptide by the PiPLC treatment. A total
of 52 identities was obtained from fragmentation of the tagged
peptides (Figure S2 and Tables S4 and S5) ranging from 1 to 15
per identity, primarily of cytosolic or cytoskeletal origin. The
PiPLC-enriched proteins of parasite origin were, in descending
order of abundance, Sm29, CD59a, Sm200, carbonic anhydrase,
CD59b, alkaline phosphatase and ADP-ribosyl cyclase (Figure 3).
In addition two host proteins, CD48 and CD90 (Thy1.2), were
also enriched by PiPLC treatment. Proteins of known gut origin,
a2-macroglobulin and saposin B, were present in control and
treated samples in equivalent amounts indicating similar regurgi-
tation of gut contents over the one hour incubation. Equivalent
amounts of cytosolic (e.g, enolase, 14-3-3) and cytoskeletal proteins
(e.g, actin, Sm20.8) in control and treated samples (Figure 3 and
Table S4) indicated a certain degree of surface damage, but not
inflicted by the PiPLC treatment. Although not enriched by
PiPLC hydrolysis, because they lack the GPI-anchor, three other
proteins are worth noting. Two of these, CD63/tetraspanin (TSP-
2) and annexin IV (Smp_074140) were already known to be
associated with the tegument surface and the third is an 8 kDa low
molecular weight protein (LMWP). This last protein, present in a
range of trematodes [10], has a signal peptide and so may be a true
secreted protein released along with the membranocalyx; its status
as a tegument surface protein needs to be confirmed.
Enzymatic shaving using PLA2
Unlike the other two enzymatic treatments PLA2 had a
dramatic effect on worm appearance and viability. Moderate
concentrations of PLA2 produced visible worm damage and
Table 1. Selected identities from trypsin shaving experiment.
Category/Protein identity Accession
a Exp1 Exp2 Exp3 Exp4
NCBInr/Smp (SmGenes) Clustered ESTs
Host proteins
haemoglobin a chain AAA37783 N
haemoglobin b-1 chain P02088 N
C3 complement AAC42013 NN
C4 complement CAA28936 NNN
CD44 CAA46880 NNN
Membrane and membrane-associated
Annexin type IV Smp_074140 Sm04814 NN
Annexin type V Smp_074150* N
Annexin type VI Smp_077720 Sm03987 NNNN
Calpain Smp_157500 Sm11826 N
Sm25 Smp_195180 Sm04760 NNN
Sm200 Smp_017730* Sm03865 NNNN
Proteoglycan-like Smp_020550 Sm08105 NN
Secretory and vesicular pathway
Potassium-channel inhibitor SmKK7 Smp_194830 Sm12916 N
Endophilin (BAR domain) Smp_003230.2 Sm04606 NNNN
Endophilin (BAR domain) Smp_163720 Sm00115* NNNN
Gut proteases
Hemoglobinase (asparaginyl endopeptidase) Sm00989 N
Cathepsin B1 isotype 1 precursor Smp_067060* Sm01772* N
aAccession numbers for host proteins can be found at Pubmed http://www.ncbi.nlm.nih.gov/protein/Smp and Sm numbers are found at http://www.genedb.org/
Homepage/Smansoni.
*Peptide hits common to more than one predicted protein.
Exp = Experiment.
doi:10.1371/journal.pntd.0000993.t001
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removing known tegumental surface components whilst still
causing leakage of cytoskeletal and cytosolic components (Table
S6). The known tegument surface proteins released were Sm29,
LMWP and dysferlin. The PLA2 approach was therefore
discontinued.
Localization of host membrane proteins
Confocal microscopy of adult worm sections revealed that host
CD44 was confined entirely to the tegument with no staining of
internal structures (Figure 4A). Examination of a Z-stack through
the tegument of an intact male worm revealed that the pattern of
staining was not uniform, being concentrated on numerous,
parallel, transverse ridges and especially the spines on the dorsal
tubercles (Figure 4B). On close inspection, the individual spines
had a definite inverted V appearance the most intense staining
being at the tip (Figure 4C). Antibodies to CD48 and CD90 failed
to detect their respective targets on the worm surface.
Transcripts for tegument surface proteins shared
between adult worms and lung schistosomula
Our in-house EST database was interrogated for the occurrence
of transcripts in lung schistosomula encoding the proteins of
interest released from adult worms by the enzyme treatments.
Although it is difficult to make inferences about abundance as
some data were obtained from normalised libraries, nearly all
transcripts were represented in both larvae and adults in roughly
similar numbers (Table 2). The exceptions were the proteoglycan
(5L and 0A) and ADP-ribosyl cyclase (0L and 1A). Transcripts for
calpain and Sm200 were particularly abundant, whilst the largest
number recorded (63) was for one of the CD59 orthologues in the
lung schistosomulum. Based on the transcript evidence we
tentatively conclude that the most exposed tegument surface
proteins of adults are also likely to be present on the surface of the
migrating lung schistosomulum.
Mapping of peptide hits for Sm200
Only one tegument surface protein, Sm200, was released by
both the trypsin and PiPLC treatments of live worms. The
difference between the two was that PiPLC released the entire
GPI-anchored molecule for subsequent trypsinisation as a separate
step. Conversely the trypsin treatment released peptide fragments
from Sm200 molecules only during the incubation period, which
were then recovered using reversed-phase chromatography.
Mapping of the peptide hits onto the primary amino acid
sequence revealed a very different pattern of distribution (Figure
S3). A total of 15 peptides, with a significant Mascot score, was
identified for the PiPLC-released protein, distributed throughout
the entire molecule. In contrast only six peptides were identified
for the trypsin-released protein and four of these were clustered
towards the C-terminus of the protein, i.e. the region located
nearest to the GPI anchor. This may indicate that only part of the
Sm200 protein is accessible to trypsin in the live worm. In this
context, the programs NetNGlyc and NetOGlyc both at http://
www.cbs.dtu.dk/services/ predicted five N (scores .0.6) but no
O-glycosylation sites on the amino acid sequence coding for
Figure 1. PiPLC-released proteins analysed by 1-DE and 2-DE. (A) Ten mg of proteins present in the culture supernatant +/2 PiPLC were
separated by 1-DE and the gel stained with SYPRO Ruby. The majority of the proteins were shared between the PiPLC-treated and non-treated
samples. Only three bands (arrowed) were visibly enriched by the treatment, two of high molecular mass at approx. 200 kDa and a third at approx.
12 kDa. (B) Fifty mg of proteins present on the PiPLC- treated supernatant were separated by 2-DE and the gel stained in SYPRO Ruby. Labelled spots
are those identified by mass spectrometry after Coomassie staining of the gel. The PiPLC protein cluster on the 2-DE map does not correlate with the
same levels of PiPLC used for preparation of 1-DE gels as they were from different sources and exhibited differing specific activities. *Less acidic CD59
isoform, see Table S3 for peptide identification data.
doi:10.1371/journal.pntd.0000993.g001
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are located furthest from the GPI anchor site in the N-terminal
region where few peptides were identified following trypsin
treatment of the live worms. Thus it is plausible that attached
N-glycans protect the native Sm200 polypeptide chain in situ on
the worm surface from trypsin attack.
Discussion
Our previous biotinylation studies have provided insights into
the disposition of proteins in the complex molecular structure of
the schistosome tegument surface. In the present study we have
taken an alternative approach to obtain information about the
location of tegument components. This involved shaving the
surface of live adult worms with selected enzymes to release
accessible proteins, and their identification by proteomics. It is
axiomatic in this approach that the integrity of the worm surface is
not compromised by the treatment. Our results indicate that
trypsin and PiPLC largely fulfilled this criterion but PLA2 did not.
We must assume that this last enzyme, via its attack on the lipid
bilayers, rapidly caused generalized erosion of the surface
membranes and loss of integrity. We shall therefore consider only
the results of the trypsin and PiPLC treatments to make inferences
about tegument surface organization. In addition, the male
parasite has at least two times the surface area of the female,
assuming all surfaces are accessible to the enzymes. If the
gynaecophoric canal is effectively sealed, then the male dorsal
surface would have contributed the bulk of released protein.
It was inevitable that the in vitro culture of live worms resulted in
the contamination of the enzyme-released proteins by gut content.
Thus the detection of proteins such as a2-macroglobulin, saposin
B, and hemoglobinase (asparaginyl endopeptidase) in the two
enzymatic shaving experiments was to be expected. Conversely,
even with the most careful handling of parasites including their
recovery from mice by perfusion with culture medium, the
presence of cytosolic and cytoskeletal proteins must be attributed
to some degree of worm damage. In the present study, we used the
iTRAQ labelling technique on test and control samples to
discriminate enzymatic enrichment from normal secretion or
protein leakage due to invisible damage. This approach success-
fully overcame the dominance of abundant peptides from
contaminating cytosolic and cytoskeletal proteins to highlight the
few proteins released by PiPLC treatment. Nevertheless, one must
bear in mind that as enzyme accessibility has not been addressed
in this investigation, caution should be exercised when considering
the fold enrichment found for GPI-anchored molecules. In this
regard, it is possible that a higher fold enrichment for a given
protein may only indicate a more exposed/accessible location at
the parasite surface rather than imply protein abundance.
A major finding of our study is that seven parasite proteins can
be detached from the surface by treatment with PiPLC and
enriched compared to control incubations. From this we infer that
each is inserted into the parasite surface by a GPI-anchor. As these
anchors are invariably located at the C-terminus of such proteins
we conclude that the extraneous 30 kDa PiPLC enzyme is able to
access the anchor in proximity to a lipid bilayer. Whether this
bilayer is the secreted membranocalyx or the underlying plasma
membrane is problematic. Access to the latter would mean that
the digesting enzyme had to pass through the protective
membranocalyx. One possible inference is that the seven GPI-
anchored proteins are inserted into the membranocalyx. For
carbonic anhydrase this seems unlikely because of its assumed
function in regulating acid-base balance at the parasite surface. It
would be best placed to do this if located between the two lipid
bilayers so that, by analogy with the erythrocyte, CO2 generated
inside the worm could be converted to HCO3
2 for diffusion into
the bloodstream. Indeed, the reverse diffusion of a chloride ion
through the membranocalyx would be required to balance the
charge, bringing it into close proximity with the anion transport-
ers, which our previous studies have shown are present in the
tegument plasma membrane [6]. The gene model for carbonic
anhydrase is incomplete, lacking both the N-terminal exon
encoding the signal peptide and the C-terminal exon(s) encoding
the site for the attachment of a GPI-anchor. However, its
enrichment by PiPLC treatment of live worms attests to the
presence of a GPI-anchor. Two isoforms of CD59 orthologues,
identified by possession of the CCxxDxCN motif, were also highly
Figure 2. Discrimination between enzymatic enrichment and
parasite leakage/secretion using iTRAQ tags. (A) Low m/z spectral
region displaying the iTRAQ reporter ion peaks whose ratios revealed a
non-GPI anchored protein. (B) Low m/z spectral region displaying the
iTRAQ reporter ion peaks whose ratios revealed a GPI-anchored protein.
C1 and C2 represent control samples labelled with the iTRAQ m/z 114
and 115 tags, respectively. T1 and T2 represent PiPLC-treated samples
labelled with iTRAQ m/z 116 and 117 tags, respectively.
doi:10.1371/journal.pntd.0000993.g002
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the surface. These proteins are potentially significant because the
human CD59 protein protects self-cells against complement
fixation by blocking formation of the C5 to C9 membrane attack
complex [11]. A similar role for the two schistosome molecules is
very attractive, as a component of the parasite’s mechanisms of
immune evasion. It is of note that in the S. mansoni genome there
are four additional gene models encoding CD59 orthologues,
which could also be tegument-associated [12]. These CD59
orthologues in the tegument surface are better candidates for
inhibition of complement fixation than the SCIP-1 protein [13],
subsequently identified as paramyosin [14,15].
The protein most highly enriched by PiPLC treatment was
Sm29 that has no known function. It was originally selected by a
bioinformatic search as a protein with a single membrane
spanning domain [16]. It was identified in the final pellet after
differential extraction in a compositional analysis of the tegument
membranes [6] and was accessible to biotinylation in live worms
Figure 3. iTRAQ consolidated results. Sixteen out of 52 proteins identified in the iTRAQ experiment selected to provide a snapshot of the major
findings provided by the PiPLC shaving approach. Fold enrichment on the y axis is plotted relative to the intensity of the m/z 114 C1 tag. The seven
GPI-anchored proteins of parasite and the two of host origin are included. Note the equivalent levels of proteins representing cytosolic, cytoskeletal,
secretory and gut contaminants present in both PiPLC-treated and control samples. C1, C2, T1 and T2 key as in Fig 2. Bars represent the standard
geometric deviation for iTRAQ ratios associated to protein identities obtained with at least 3 peptide fragmentations. iTRAQ ratios and protein
identities obtained from fragmentations of 1 and 2 peptides are reported based on their significant Mascot expect score (,0.05) in three
independent iTRAQ experiments.
doi:10.1371/journal.pntd.0000993.g003
Figure 4. Immunocytochemistry of host CD44 on the S. mansoni tegument surface. (A) OTC-embedded parasite sections and (B/C) freshly
perfused live parasites were labelled with rat anti-mouse CD44. In worm sections, CD44 staining was confined exclusively to the parasite surface.
Figure (A) represents the CD44 staining of the tegument in the ventral sucker region. (B) Slice from a Z-stack of the male tegument after CD44
staining of live worms. (C) Higher magnification of (B) showing a striking inverted V pattern for CD44 staining being mostly concentrated at the tip of
the spines (arrowed).
doi:10.1371/journal.pntd.0000993.g004
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the tegument although technical issues do not allow a firm
conclusion about its precise location [17]. Our PiPLC shaving
results demonstrate both its peripheral location and the fact that it
is GPI-anchored, the latter prediction also made by big-PI
Prediction server (http://mendel.imp.ac.at/gpi/gpi_server.html).
The peripheral location of Sm200, again with no known function,
was also revealed by PiPLC shaving. This protein first cloned by
Hall et al. [18] was already known to be GPI-anchored and
located in the tegument surface [19,20]. Surprisingly therefore it
was not found in compositional analysis of the tegument
membrane [6], but was accessible to biotinylation in live worms
[7]. These observations suggest that whilst definitely surface-
attached it is readily lost during the processing of tegument
membranes by differential extraction for MS analysis, a feature
that may be linked both to its size and GPI-anchor. Moreover,
Sm200 has recently been identified in circulating lipoprotein
particles from the blood of schistosome-infected humans, con-
firming its turnover into the vascular environment [21].
The two remaining GPI-anchored proteins shown to be
enriched by iTRAQ labelling after PiPLC treatment were alkaline
phosphatase and ADP-ribosyl cyclase. The former is well
characterized and was previously shown to be GPI-anchored in
schistosomula [22]. It has been used as a membrane marker in the
development of methods for tegument surface isolation [5]. It was
identified by compositional analysis of the tegument surface
membranes in the urea/thiourea/CHAPS/sulfobetaine (UTCS)
fraction and insoluble pellet [6], and is accessible to biotinylation
in live worms [7]. Its presence in the UTCS fraction indicates that
it is, at least partially, loosely associated with the surface
membranes i.e not membrane spanning. The recently charac-
terised ADP-ribosyl cyclase was also shown to be GPI-anchored
and localized to the outer tegument of the adult schistosome [23].
Both schistosome enzymes must be able to access their substrates
in live worms but their precise function at the tegument surface
remains to be established. In the case of ADP-ribosyl cyclase, a
role in calcium mobilization has been proposed [23] but
alternatively it could function in immune evasion by regulating
ecto-NAD+ levels, thereby reducing substrate availability for
CD38- and CD157-mediated effector functions of lymphocytes.
Corroborating the identification of GPI-anchored molecules using
the iTRAQ technique, four out of the seven proteins assigned as
GPI-anchored were also detected by our 2-DE analysis. These
were Sm200, alkaline phosphatase, two isoforms of CD59
orthologues and carbonic anhydrase. A definite proof of their
enrichment due to PiPLC’s activity is the fact that these molecules
are underrepresented and are not easily identifiable in 2-DE maps
produced using soluble worm preparations [8] or membrane-
extracted proteins from crude or differentially-extracted S. mansoni
tegument [6].
Use of the iTRAQ technique to identify proteins enriched by
trypsin treatment was not possible because the released material
was already partially digested. This prevents accurate quantifica-
tion of protein for labelling and therefore the trypsin shaving
fraction was subsequently processed as a peptide digest. We have
taken as a reference of cytosolic/cytoskeletal contaminants in the
trypsin shaving, the number and diversity of those proteins
released during 1 h incubation at 37uC in the absence of added
enzyme. When we compared the number of proteins that could
indicate leakage or vomitus with the number of proteins in the
trypsin-treated parasites, we observed we had less contamination,
most likely due to a shorter incubation time, 30 min. In addition,
we are assuming that as trypsin should not be able to permeate the
parasite tissues, the peptides originating from membrane proteins
are likely to represent the most exposed/accessible domains at the
parasite surface. We therefore focus only on (1) membrane and
membrane-associated, (2) vesicular pathway and secreted, and (3)
host proteins. The peripheral location of Sm200 was again
confirmed but it was the only one of the seven PiPLC-released
proteins that was also released by trypsin. This suggests that the
rest may be protected from proteolysis, potentially by their N and/
or O-linked glycans or by a sequestered location. The release of
three annexins by the trypsin treatment indicates their superficial
location. One (Smp_077720) was previously detected by both
biotinylation and compositional analysis and two are new to this
study (Smp_074140 and Smp_074150). The known phospholipid-
binding properties of this group of proteins means that they could
have a role in promoting adhesion of the membranocalyx to the
plasma membrane, acting like a molecular ‘velcro’ via the four
binding domains that each possesses. More recently, certain
annexin isoforms have been implicated in immunomodulatory
functions such as the resolution of inflammation [24]. They are
able to interact with receptors on the surface of leukocytes to
control apoptosis and their clearance by macrophages. The
existence of such a process at the surface of the tegument,
mediated by schistosome annexins, accords with the absence of
leukocyte binding to adult worms in vivo [25]. However, a
comparison of the orthologies of the schistosome and human
annexins is difficult because of the evolutionary distance. Thus,
BLAST searching of the schistosome sequences against the
NCBInr database reveals the closest homologues of Smps
077720, 075150 and 075140 are human annexins A13, A7 and
A8 respectively, not the A1 isoform that has been most implicated
as an anti-inflammatory agent. The conjecture will only be
resolved by expression of the schistosome annexins for assays of
function.
The presence of Sm25 as a tegument surface protein has a
chequered history. It was proposed as a vaccine candidate because
anti-Sm25 antibody levels correlated with protection in mice
vaccinated with a crude tegument membrane preparation [26]. It
was then cloned and designated as an N-glycosylated integral
Table 2. Number of transcripts for tegument surface proteins
shared between lung schistosomula (L) and adult worms (A).
Protein Gene model L A
Annexin type IV Smp_074140 4 3
Annexin type V Smp_074150 1 8
Annexin type VI Smp_077720 7 6
Calpain Smp_157500 17 21
Sm25 Smp_195180 2 2
Sm200 Smp_017730 11 23
Proteoglycan-like Smp_020550 5 0
Endophilin (BAR domain) Smp_003230 2 13
Endophilin (BAR domain) Smp_163720 4 8
Sm29 Smp_072190 2 6
CD59/Ly6 (CD59a) Smp_019350 2 4
CD59/Ly6 (CD59b) Smp_105220 63 3
Alkaline phosphatase Smp_155890 4 10
Carbonic anhydrase Smp_168730 2 3
ADP-ribosyl cyclase (SARC) Smp_025830 0 1
Tetraspanin TSP-2 Smp_181530 6 15
doi:10.1371/journal.pntd.0000993.t002
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protein with the implication that it was on the cytosolic leaflet of
the plasma membrane [28]. Further immunocytochemical studies
suggested it was distributed throughout the tegument syncytium
but not associated with the surface membranes [29] and it could
only be biotinylated when parasites were permeabilized by Triton
X-100 [30]. It was not found in either our compositional or
biotinylation studies on the tegument surface. The removal of
Sm25 from live worms by trypsin, when so few other membrane
proteins are released, suggests a unique accessibility. The
proteolytic enzyme calpain was previously identified at the
tegument surface by both compositional analysis [6] and
biotinylation [7]; its potential as a vaccine candidate has already
been exploited [31,32]. The final member of this group is a
heparin sulphate-like proteoglycan which has not been identified
in any previous studies and merits further investigation. In the
secreted protein category, this is the first report of SmKK7 release
from the tegument surface; it has previously only been reported
from cercarial secretions [33]. The detection of a pair of BAR
domain proteins in all four experiments after trypsin treatment is
intriguing since these banana-shaped molecules located on the
cytosolic surface of plasma membranes function to promote
membrane curvature in exo- and endocytosis [34]. This suggests
that the trypsin may be entering the fine tubules located at the
base of tegument pits where multilaminate vesicle fusion with the
tegument plasma membrane occurs [35,36]. That conclusion
would place Sm25 and the proteoglycan in a similar location
where constituent proteins are poorly protected by overlying
membranocalyx, perhaps loosely analogous to the relationship of
the flagellar pocket of trypanosomes [37] to variant surface
glycoprotein export.
The release of complement C3 from the parasite surface by
trypsin treatment is consistent with our previous biotinylation
study [7]. We can now add C4, its precursor in the complement
cascade, but not the C5 to C9 components of the membrane
attack complex, suggesting complement fixation but then inhibi-
tion of the cascade. The failure to detect any immunoglobulins,
when murine IgM, IgG1 and IgG3 heavy chains were biotinylated
[7], is puzzling as they would be expected to initiate complement
fixation. However, there is evidence that these proteins are
resistant to trypsin degradation, particularly under the low
concentration conditions employed in our experiments [38]. In
fact, aiming to preserve worm viability, trypsin was used at a
concentration approximately 100 times lower than that typically
employed for stripping adherent cells from culture flasks. A
positive consequence of such a gentle shaving treatment on live
worms is justified by the reasonable number of genuine membrane
proteins that were identified. In contrast, a previous study on S.
bovis with trypsin treatment, used methanol-fixed parasites [39]
and found an overall higher number of protein identifications.
However, membrane-associated and/or integral proteins were
poorly represented, and the results are not comparable with our
approach using live worms.
Our enzyme shaving experiments extend the list of host proteins
known to be firmly associated to the parasite surface. The release
of CD48 and CD90 (Thy1.2) by PiPLC confirms their possession
of GPI-anchors and most likely accounts for their transference
from the host (leukocytes) in the same manner as host glycolipids
transfer from erythrocytes through a process currently termed cell-
painting [40]. Supporting this finding is the demonstrable ability of
purified Thy-1to reincorporate into the plasma membrane of
murine Thy-1- cells directly from aqueous suspension and without
the use of detergents [41]. However, failure to detect the presence
of both CD48 and CD90 by immunocytochemistry indicates their
relative paucity. The detection of host CD44 is more surprising
since it is an extracellular protein anchored in the membrane of a
range of cell types by a single transmembrane domain [42].
However, the intense staining of the tips of spines on the dorsal
tubercles, the point of contact between the worm and the vascular
endothelium during peregrination around the portal vasculature,
suggests that the transfer occurs when the apposing membranes of
tegument and endothelium are pressed together. The observations
on CD44 staining are a testament to the acquisitive properties of
the schistosome surface.
Our studies on the surface accessibility of tegument proteins are
relevant to the development of schistosome vaccines. In mice
immunized with attenuated cercariae challenge schistosomula are
eliminated in the lungs by inflammatory foci that block their
onward migration [43]. Both priming of the immune response
[44] in skin-draining lymph nodes and the pulmonary effector
responses appear to be mediated by proteins on the schistosomular
tegument surface [45]. Although we have characterised surface
proteins on the adult worm, the presence of the encoding mRNAs
in the lung schistosomulum provides support for the suggestion
that those same proteins are exposed on the larval tegument
surface. In this context Sm29 has already been used successfully as
a vaccine candidate [17]. We therefore suggest that the other six
PiPLC-anchored proteins would also repay investigation as
putative vaccine candidates, especially Sm200 because it was also
removed by trypsin. Indeed, the presence of a GPI-anchor may
make proteins in this group more prone to detachment from the
surface for transcytosis across the pulmonary capillary endotheli-
um, processing by accessory cells and presentation to reactive
CD4+ Th1 cells in the lung parenchyma. To this list we can add
the three annexins released by trypsin and LMWP that may be a
tegument secretion, noting also that calpain is a proposed vaccine
candidate [31]. It is conceivable that a cocktail of these proteins
would elicit strong protection against intravascular migrating
schistosomula, especially if targeted to the lungs, whereas
immunisation with a single protein has only modest success [46].
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